Efficacy of SIGMAR1-based therapy in the early treatment of confirmed mild symptomatic COVID-19 patients
Loading...
Identifiers
Publication date
Advisors
Tutors
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
Abstract
Description
Keywords
Bibliographic citation
Santiago Grau, José Miguel Vela, Alba Gurt, Jaime Barceló-Vidal, Fabiola Ojeda, Iago López, Laura Gómez-García, María Isabel Loza, Elena Martín-García, Rafael Maldonado, Jordi Monfort, Efficacy of SIGMAR1-based therapy in the early treatment of confirmed mild symptomatic COVID-19 patients, Journal of Infection, Volume 88, Issue 2, 2024, Pages 187-190, ISSN 0163-4453, https://doi.org/10.1016/j.jinf.2023.11.008
Relation
Has part
Has version
Is based on
Is part of
Is referenced by
Is version of
Requires
Publisher version
https://doi.org/10.1016/j.jinf.2023.11.008Sponsors
This work was supported by the Spanish “Minsterio de Ciencia e Innovación (MICIN), Agencia Estatal de Investigación (AEI)” (PID2020-120029GB-I00/MICIN/AEI/10.13039/501100011033) to RM; the “Generalitat de Catalunya, AGAUR” (2017 SGR-669) to RM; the “ICREA-Acadèmia” (2020) to RM; and the Spanish “Instituto de Salud Carlos III, RETICS-RTA” (RD16/0017/0020) to RM. We gratefully acknowledge grant support from Xunta de Galicia through the call for proposals RESCATA-COVID (IN845D 2020/19) and the European Regional Development Fund (ERDF). This work has also been co-financed by the Ministry of Science and Innovation, Spain, with funds from the European Union NextGenerationEU (PRTRC17.I1) and the Autonomous Community of Galicia within the framework of the 2023 Biotechnology Plan Applied to Health. Finally, this work received partial financial support from Esteve Pharmaceuticals S.A.
Rights
Attribution-NonCommercial-NoDerivatives 4.0 International